PolyNovo (PNV:ASX) Annual Reports & Investor Relations Material

Overview

PolyNovo Biomaterials Pty Ltd. is a leading developer and owner of a novel biodegradable polymer technology known as NovoSorb TM. The company specializes in developing regenerative devices for reconstructive surgery and tissue repair using its patented polymer technology. Its NovoSorb TM technology is used in a wide range of medical applications, including orthopedic surgery, wound care, and neurosurgery. PolyNovo is a well-established player in the medical device industry, with a strong track record of innovation and product development. The company is committed to advancing the state of the art in regenerative medicine and improving outcomes for patients in need of surgical intervention.

Frequently Asked Questions

What is PolyNovo's ticker?

PolyNovo's ticker is PNV

What exchange is PolyNovo traded on?

The company's shares trade on the ASX stock exchange

Where are PolyNovo's headquarters?

They are based in Port Melbourne, Australia

How many employees does PolyNovo have?

There are 11-50 employees working at PolyNovo

What is PolyNovo's website?

It is http://www.polynovo.com.au

What type of sector is PolyNovo?

PolyNovo is in the Healthcare sector